1-10 of 10
Heather E Oakervee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase III Study (ADMYRE) of Plitidepsin in Combination with Dexamethasone Vs. Dexamethasone Alone in Patients with Relapsed/Refractory Multiple Myeloma

Ivan Spicka, MDPhD, Enrique M. Ocio, MDPhD, Heather E. Oakervee, MBBS MD, Richard Greil, MD, Raymond H. Banh, MD, Laurence Catley, MD, Shang-Yi Huang, MD, PhD, James M. D'Rozario, MBBS FRACP FRCPA, Meletios A. Dimopoulos, José Rodríguez, MDPhD, Sara Martinez, MD, Sonia Extremera, BsC, Vicente Alfaro, MsC PhD, Angelo Michele Carella, MD, Nathalie Meuleman, MDPhD, Roman Hájek, MD, Argiris Symeonidis, MD PhD, Chang-Ki Min, MD, Paul Cannell, MD, Heinz Ludwig, MD, Pieter Sonneveld, MDPhD, Maria V. Mateos, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1886.
https://doi.org/10.1182/blood.V130.Suppl_1.1886.1886
Published: 2017
Journal Articles

Cancer-Selective Targeting of the NF-κB Survival Pathway in Multiple Myeloma with the GADD45β/MKK7 Inhibitor, DTP3

Laura Tornatore, Gary Acton, Nigel Adams, Elizabeth A Campbell, James Kelly, Richard M Szydlo, BSc, PhD, Mike Tarbit, Salina Bannoo, Daniel D'Andrea, Daria Capece, Annamaria Sandomenico, Julian Dyson, Antonio Leonardi, Christoph Driessen, Menotti Ruvo, Ishara Anees, Metod Oblak, Sheena Quaid, Magda J Al-Obaidi, Holger Auner, Reuben Benbenjamin, Richard S Kaczmarski, Martin F Kaiser, Atul Mehta, Heather E Oakervee, Stephen A Schey, Ashutosh Wechalekar, Jane F. Apperley, MD, Guido Franzoso
Journal: Blood
Blood (2015) 126 (23): 868.
https://doi.org/10.1182/blood.V126.23.868.868
Published: 2015
Journal Articles

Bortezomib (Velcade), Thalidomide, Dexamethasone and Panobinostat (VTD-P) Is a Safe, Well Tolerated and Efficacious Regimen for Patients with Relapsed Multiple Myeloma: Preliminary Results of the Muk-Six Trial

Rakesh Popat, MBBS, PhD, Sarah R Brown, Louise M Flanagan, Andrew Hall, Bhuvan Kishore, MBBS, FRPATH, MRCP, Matthew Streetly, Heather E Oakervee, Simon L. Hallam, Matthew Smith, MBBS, MA, MRCP, MRCPath, MD, Kwee L Yong, MBChB, PhD, Gordon Cook, MD PhD, James D. Cavenagh, MD
Journal: Blood
Blood (2015) 126 (23): 1826.
https://doi.org/10.1182/blood.V126.23.1826.1826
Published: 2015
Journal Articles

Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)

Rakesh Popat, James D Cavenagh, MD, Roger G Owen, MD, Matthew Streetly, Stephen A Schey, MD, Mickey Koh, MD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres Virchis, Gordon Cook, MD PhD, Charles Crawley, Guy Pratt, Mark Cook, PhD FRCPath, Heather E. Oakervee, MBBS, BSc, MD MRCP, FRCPath, Nicholas Counsell, Toyin Adedayo, Alison Evans, Nivette Braganca, Paul Smith, MSc, Janet lyons-Lewis, Neil Rabin, Kwee L Yong, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4745.
https://doi.org/10.1182/blood.V124.21.4745.4745
Published: 2014
Journal Articles

Differential and tumor-specific expression of CD160 in B-cell malignancies

Timothy W. Farren, Jerome Giustiniani, Feng-Ting Liu, Dimitris A. Tsitsikas, Marion G. Macey, James D. Cavenagh, Heather E. Oakervee, David Taussig, Adrian C. Newland, Maria Calaminici, Armand Bensussan, Michael Jenner, John G. Gribben, Samir G. Agrawal
Journal: Blood
Blood (2011) 118 (8): 2174–2183.
https://doi.org/10.1182/blood-2011-02-334326
Published: 2011
Includes: Supplemental data
Journal Articles

A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report.

Dimitris A Tsitsikas, Dana Warcel-Sibony, Heather E. Oakervee, MBBS, BSc, MD, MRCP, FRCPath, Samir G Agrawal, Matthew Smith, David C Taussig, PhD, MRCP, FRCPath, Johannes de Vos, Elaine Stewart, Hannah Nicholas, John G. Gribben, MD, DSc, James D Cavenagh
Journal: Blood
Blood (2010) 116 (21): 3480.
https://doi.org/10.1182/blood.V116.21.3480.3480
Published: 2010
Journal Articles

Development of original donor cell leukemia after successful engraftment from a second donor

Jane M. Stevens, Denise Syndercombe-Court, Heather E. Oakervee, Daniel McCloskey, Michael J. Jenner, John G. Gribben, Jamie D. Cavenagh
Journal: Blood
Blood (2007) 110 (13): 4621–4622.
https://doi.org/10.1182/blood-2007-07-104240
Published: 2007
Journal Articles

Bortezomib, Adriamycin Dexamethasone (PAD) Combination Therapies or Patients with Relapsed or Refractory Myeloma Previously Treated with VAD or VAD like Therapy.

Treen C. Morris, Mary Drake, Paul J. Kettle, Aishleen Brunton, James D. Cavenagh, Heather E. Oakervee, Michael O’Dwyer, Margaret Murray, Tanya O’Shea, Gordon Cook
Journal: Blood
Blood (2006) 108 (11): 5117.
https://doi.org/10.1182/blood.V108.11.5117.5117
Published: 2006
Journal Articles

Reduced Dose PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma.

Rakesh Popat, MBBS, Heather E. Oakervee, MRCPath, Nicola Curry, MBBS, Nicola Foot, BSc, Curly Morris, FRCP, Mary Drake, MRCPath, Samir Agrawal, PhD, Patricia Smith, RGN, David Schenkein, MD, Dixie-Lee Esseltine, MD, Jamie D. Cavenagh, MD
Journal: Blood
Blood (2005) 106 (11): 2554.
https://doi.org/10.1182/blood.V106.11.2554.2554
Published: 2005
Journal Articles

A Phase I/II Study of Bortezomib and Low Dose Intravenous Melphalan (BM) for Relapsed Multiple Myeloma.

Rakesh Popat, DipRCPath, Heather E. Oakervee, MRCPath, Nicola Foot, BSc, Samir Agrawal, PhD, Patricia Smith, RGN, Charles Craddock, FRCPath, Catherine Williams, FRCPath, Supratik Basu, FRCPath, Jamie D. Cavenagh, MD
Journal: Blood
Blood (2005) 106 (11): 2555.
https://doi.org/10.1182/blood.V106.11.2555.2555
Published: 2005